Basit öğe kaydını göster

dc.contributor.authorDal, Derya
dc.contributor.authorSarac, Ozge
dc.contributor.authorToklu, Yasin
dc.contributor.authorKocak Altintas, Ayse Gul
dc.contributor.authorCakmak, Hasan Basri
dc.contributor.authorDamar Gungor, Elif
dc.contributor.authorSimsek, Saban
dc.date.accessioned2019-12-12T06:46:23Z
dc.date.available2019-12-12T06:46:23Z
dc.date.issued2017
dc.identifier.issn2090-004X
dc.identifier.urihttps://doi.org/10.1155/2017/4271671
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733172/
dc.identifier.urihttp://hdl.handle.net/11655/16990
dc.description.abstractBackground To evaluate the effects of topical 0.5% ketorolac treatment combined with topical steroids on macular thickness in cases who had uneventful phacoemulsification surgery. Methods 58 eyes of 58 consecutive cases were included. The mean foveal thickness (MFT), parafoveal thickness (ParaFT), and perifoveal thickness (PeriFT) measurements were performed with optical coherence tomography (RTVue-100, Optovue, Fremont, CA, USA) preoperatively and at postoperative 1 week, 1 month, and 2 months. All cases received topical 0.1% dexamethasone postoperatively. Randomly selected cases additionally received topical 0.5% ketorolac, which started 2 days prior to surgery. Cases who received both topical steroids and ketorolac formed group 1 and subjects who received only topical steroids formed group 2. Results The increase in mean MFT at the 1st week, 1st month, and 2nd months after surgery in group 1 was significantly lower than group 2 (P = 0.008, P ≤ 0.001, and P ≤ 0.001, resp.). In group 1, the increase in mean ParaFT and PeriFT was significantly lower than group 2 at the 1st and 2nd months of the surgery (P < 0.05 for all variables). Conclusions Topical ketorolac combined with steroids is highly efficacious in order to prevent increment in thickness on each part of the macula even after an uneventful phacoemulsification surgery comparing to steroid monotheraphy.
dc.relation.isversionof10.1155/2017/4271671
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe Effect of Perioperative Topical Ketorolac 0.5% on Macular Thickness After Uneventful Phacoemulsification
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalJournal of Ophthalmology
dc.contributor.departmentGöz Hastalıkları
dc.identifier.volume2017
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster